Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03466151 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT03466151 · ClinicalTrials.gov record · last posted 2026-04-22

RESOLUTE ONYX China RCT Study

StatusActive, Not Recruiting
PhaseNot applicable
Started2018-04-12
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
It is a randomized controlled trial to evaluate the safety and efficacy of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in comparison with the Medtronic Resolute Integrity™ Zotarolimus-Eluting coronary stent system in the treatment of subjects eligible for percutaneous transluminal coronary angioplasty (PTCA) in China.

Amendment record 19 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 19 times since 2018-03-08; most recent amendment 2026-04-17. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2019-06-03
Status change Recruiting→Active, Not Recruitingv5
2018-04-12
Status change Not Yet Recruiting→Recruitingv2
Trial Details
NCT Number NCT03466151
Lead Sponsor Medtronic Vascular
Conditions Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases, Arteriosclerosis, Coronary Artery Disease
Enrollment 550 participants
Start Date 2018-04-12
Primary Completion 2021-02-12 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-22